Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis

BACKGROUND: Poor accrual is a significant barrier to the successful completion of oncology clinical trials; half of all phase 3 oncology trials close due to insufficient accrual. Timely access to accrual data fosters an understanding of successful trial design and can be used to inform the design of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Aaron P, Hirsch, Bradford R, Abernethy, Amy P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987844/
https://www.ncbi.nlm.nih.gov/pubmed/24661848
http://dx.doi.org/10.1186/1745-6215-15-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987844/
https://www.ncbi.nlm.nih.gov/pubmed/24661848
http://dx.doi.org/10.1186/1745-6215-15-92

Ejemplares similares